z-logo
open-access-imgOpen Access
Diabetes, Metabolic Syndrome, and Obesity in Relation to Serum Dioxin Concentrations: The Seveso Women’s Health Study
Author(s) -
Marcella Warner,
Paolo Mocarelli,
Paolo Brambilla,
Amelia K. Wesselink,
Steven J. Samuels,
Stefano Signorini,
Brenda Eskenazi
Publication year - 2013
Publication title -
environmental health perspectives
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.257
H-Index - 282
eISSN - 1552-9924
pISSN - 0091-6765
DOI - 10.1289/ehp.1206113
Subject(s) - medicine , metabolic syndrome , obesity , glycated hemoglobin , hazard ratio , diabetes mellitus , body mass index , odds ratio , endocrinology , cohort , cohort study , physiology , type 2 diabetes , confidence interval
In animal studies, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters glucose transport and increases serum lipid levels and blood pressure. Epidemiologic evidence suggests an association between TCDD and metabolic disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom